The Skin Barrier in Users of Diabetes Devices

Launched by JANNET SVENSSON · Feb 26, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how diabetes devices, like insulin pumps and continuous glucose monitors, affect the skin of people with type 1 diabetes. While these devices help manage diabetes, they can sometimes cause skin problems, such as irritation or allergic reactions, and a condition called lipohypertrophy, where fatty lumps develop under the skin. The researchers want to understand how these issues happen and how different factors, like the type of device used or preventive treatments, can help protect the skin. They will use non-invasive methods to look at blood flow and the skin barrier, which is important for keeping the skin healthy.

To participate in this trial, you must be diagnosed with type 1 diabetes and currently using a diabetes device attached to your skin, like an insulin pump or a continuous glucose monitor. The study will involve some simple tests that do not hurt and will help researchers find better ways to design diabetes devices and provide guidance on how to use them safely. This research aims to improve the overall care and health outcomes for people living with diabetes.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosed with type 1 diabetes
• • using diabetes device attached to the skin (insulin pump or CGM)
• Exclusion Criteria:
• • Do not use diabetes device attached to the skin.
• • Those unable to read and understand Swedish or English
• • impaired cognitive development that may interfere with the ability to answer questionnaires in Swedish/English and/or be reached by phone.